Link Pharma Chem

  • Market Cap: Micro Cap
  • Industry: Commodity Chemicals
  • ISIN: INE302F01011
  • NSEID:
  • BSEID: 524748
INR
25.25
-1.7 (-6.31%)
BSENSE

Oct 09

BSE+NSE Vol: 153

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Vivid Global
Kobo Biotech
Link Pharma Chem
Jayshree Chem.
Sreechem Resins
Kuwer Industries
Tulasee Bio-Eth.
Square Four Pro.
Emmessar Biotech
Omkar Pharmachem
Bhagawati Oxygen
Why is Link Pharma Chem Ltd ?
1
Weak Long Term Fundamental Strength with a -37.12% CAGR growth in Operating Profits over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.37
  • The company has been able to generate a Return on Equity (avg) of 3.60% signifying low profitability per unit of shareholders funds
2
Flat results in Jun 26
3
Stock is technically in a Mildly Bearish range
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -15.40% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Commodity Chemicals)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Link Pharma Chem for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Link Pharma Chem
-27.86%
-0.25
60.69%
Sensex
-11.8%
-0.48
13.44%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-8.01%
EBIT Growth (5y)
-37.12%
EBIT to Interest (avg)
0.37
Debt to EBITDA (avg)
1.11
Net Debt to Equity (avg)
0.52
Sales to Capital Employed (avg)
1.79
Tax Ratio
30.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
5.74%
ROE (avg)
3.60%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
492764035212392896
Industry P/E
42
Price to Book Value
0.94
EV to EBIT
18.64
EV to EBITDA
14.91
EV to Capital Employed
0.96
EV to Sales
0.66
PEG Ratio
4927640352123929.00
Dividend Yield
NA
ROCE (Latest)
-0.51%
ROE (Latest)
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
NET SALES(Q)

Highest at Rs 8.77 cr

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Link Pharma Chem
Net Sales - Quarterly
Highest at Rs 8.77 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Net Sales - Quarterly
At Rs 8.77 cr has Grown at 27.9% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 6.86 Cr
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)